查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2129071

治療藥物市場：按類型、適應症、最終用戶、國家和地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Curative Therapeutics Market, By Type, By Indication, By End User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 350 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，治療療法市場價值將達到 209.83 億美元，從 2026 年到 2033 年將以 10.6% 的複合年成長率成長。

根治性治療是指旨在消除疾病根本原因的療法，而不僅僅是緩解症狀或阻止疾病進展。過去的治療方法著重於治療症狀或抑制病理過程，而根治性治療則透過手術介入、細胞和基因操作以及病原體清除等手段，幫助患者恢復健康。對於遺傳性疾病、感染疾病和代謝失調等疾病而言，根治性治療具有巨大的變革潛力，並將展現出極高的價值。與旨在治癒疾病或緩解症狀的慢性病治療不同，針對病理過程的根治性治療能夠徹底治癒患者的疾病。這些療法透過提供持久的疾病緩解和改善患者的預後，正在改變醫療保健產業。

治療性治療市場－市場動態

人們對罕見疾病治療需求的認知不斷提高，正在推動市場需求。

人們對罕見疾病和孤兒病的日益關注正在推動市場成長。對這些疾病更深入的了解、診斷技術的進步以及對未滿足需求的關注，正在加速治癒性和緩解疾病療法的研發和應用。例如，根據英國政府2026年4月發布的《英格蘭罕見疾病行動計劃》，每17人中就有1人會在一生中的某個階段患上罕見疾病。英國國家醫療服務體系（NHS）基因組醫學服務（GMS）已針對7,000多種獨特的疾病提供基因組檢測，預計到2025年1月，將透過基因組技術完成超過34萬次檢測。至2025年，預計將進行超過34萬次罕見疾病基因組檢測（其中超過4萬次為全基因組檢測）。此外，英國國家醫療服務體系（NHS）已建立28個罕見疾病合作研究網路和兩個試點中心，為患有未確診罕見疾病的兒童和成人提供服務。這些措施旨在提高公眾對罕見疾病的認知，促進診斷，並提高患者獲得創新療法的機會。

治療療法市場－市場區隔分析：

全球治療藥物市場按類型、適應症、最終用戶和地區進行細分。

由於緩解疾病藥物能夠改變疾病的發病機制並實現持續治療，因此其市場佔有率相當可觀。例如，根據美國國家生物技術資訊中心（NCBI）的數據，截至2025年12月，緩解疾病抗風濕藥物（DMARDs）分為三類：傳統DMARDs、生物製藥和標靶合成DMARDs。 NCBI指出，目前有六種生物DMARDs，包括Infliximab、Adalimumab、Etanercept、Rituximab、阿巴西普和托珠單抗。值得注意的是，生物DMARDs通常透過腸外途徑（靜脈注射或皮下注射）給藥。預計這將擴大疾病修正治療的應用範圍，並改善這些疾病的治療選擇。

治療性療法市場—區域分析

北美地區治療性療法市場預計將繼續保持其銷售佔有率的領先地位，這主要得益於該地區疾病的高發生率、完善的醫療保健體系、積極的研發活動以及蓬勃發展的製藥和生物技術產業。例如，根據美國勞工統計局（BBS）截至2026年4月的數據，印度將成為美國最大的藥品和醫療產品出口國，出口額將達314億美元。緊隨其後的是第二的波多黎各（167億美元）、第三位的北卡羅來納州（143億美元）、加州（95億美元）、伊利諾州（86億美元）和賓州（77億美元）。這些出口數據表明，美國主要州和地區都擁有成熟的製藥生產基地。

受人口成長、疾病負擔加重、醫療成本上升以及醫療格局變化等因素的推動，亞太地區預計將經歷顯著成長。根據印度政府2026年6月發布的公告，公共衛生基礎設施預計將透過在運作印度的18.6萬個AYUSH中心提供公共衛生服務而持續擴展。這些中心包括13.4萬個基層醫療中心、24483個初級衛生中心、5474個都市區初級衛生中心、12259個AYUSH中心和9758個都市區健康與保健中心。此外，總理健康促進和綜合管理計劃（PM-ABHIM）已獲得6418億盧比的總預算撥款，為23224個農村健康與健康中心、13736個城市健康與健康中心、3389個區級公共衛生單位、744個綜合公共衛生實驗室和631個重症監護病房提供服務。預計這些進展將加強醫療保健服務的可近性，並繼續推動對醫療保健服務需求的成長。

目錄

第1章 治療市場概覽

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章 治療領域的主要市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：治療產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章 治療市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章 治療市場現狀

  • 治療性療法市佔率分析，2025 年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 治療市場：依類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按類型
    • 細胞療法
    • 基因治療
    • 生物修飾劑

第8章 治療市場：依適應症分類

  • 概述
    • 基於細分市場的市佔率分析：按適應症
    • C型肝炎
    • 罕見疾病
    • 神經退化性疾病
    • 肌肉骨骼疾病
    • 癌症
    • 其他

第9章 治療市場：依最終使用者分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 學術和研究機構
    • 製藥公司
    • 其他

第10章 治療市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章：主要供應商分析：治療業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Sarepta Therapeutics, Inc.
    • Vertex Pharmaceuticals Incorporated
    • Alnylam Pharmaceuticals, Inc.
    • Amgen Inc.
    • Beam Therapeutics Inc.
    • CRISPR Therapeutics AG
    • Intellia Therapeutics, Inc.
    • Cartesian Therapeutics, Inc.
    • Curative Biotechnology, Inc.
    • CureAge Therapeutics
    • Jnana Therapeutics, Inc.
    • Kymera Therapeutics, Inc.
    • MiNA Therapeutics Ltd.
    • Seagen Inc.
    • Cellectis SA
    • Editas Medicine, Inc.
    • Sangamo Therapeutics, Inc.
    • Precision BioSciences, Inc.
    • Others

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7407

Curative Therapeutics market size was valued at US$ 20,908.3 Million in 2025, expanding at a CAGR of 10.6% from 2026 to 2033.

Curative therapeutics are basically the treatment procedures which have the ability to get rid of the cause of a disease, as opposed to just treating symptoms and preventing disease progression. On the other hand, they have been used to treat symptoms or stop the pathological process, but curative therapies can help bring back the health of patients through surgical intervention, cellular and genetic manipulation and getting rid of the pathogenic agents, and this could be highly valuable when considering diseases like genetic disorders, cancer, infections and metabolic diseases, as there is a lot of transformative power in all these various fields. Unlike chronic disease treatments which have been aimed at curing or relieving the symptoms of a disease, curative therapies that target the pathological process would definitely cure a patient of such a disease. These therapies are reshaping healthcare by offering lasting disease resolution and improved patient outcomes.

Curative Therapeutics Market- Market Dynamics

Growing Recognition of Rare Disease Treatment Needs to Propel Market Demand

Growing recognition of rare and orphan diseases is helping to grow the market, as more awareness about diseases, better diagnosis, and concentration on unmet medical needs are prompting the development and adoption of curative and disease-modifying drugs. For instance, in April 2026, according to the UK government's England Rare Diseases Action Plan, rare diseases collectively affect 1 of 17 people during their lifetime. The UK Govt. Rare Diseases Action Plan stated that there are more than 7,000 unique conditions for which the NHS Genomic Medicine Service (GMS) can conduct genomic tests in England, while more than 340,000 will be provided through genome technologies by January 2025. It will have performed more than 340,000 genomic tests for rare diseases, including more than 40,000 whole-genome equivalents, by 2025. In addition, the NHS had established 28 Rare Disease Collaborative Networks and 2 pilot centers for children and adults with rare diseases that are still undiagnosed. These initiatives are strengthening rare disease recognition, diagnosis, and access to innovative therapeutic solutions.

Curative Therapeutics Market- Segmentation Analysis:

The Global Curative Therapeutics market is segmented on the basis of Type, Indication, End User, and Region.

The biology-modifying drugs segment holds a significant share because of the ability to modify disease pathogenesis and deliver continuous treatment. For instance, in December 2025, according to the National Center for Biotechnology Information (NCBI), Disease-Modifying Antirheumatic Drugs (DMARDs) are grouped into 3 types, which are traditional DMARDs, biologics, and targeted synthetic DMARDs. The National Center for Biotechnology Information (NCBI) states that there are 6 biologic DMARDs, including infliximab, adalimumab, etanercept, rituximab, abatacept, and tocilizumab. It should be noted that biologic DMARDs are administered in a parenteral manner (intravenously and subcutaneously). This provides opportunities for improved treatment options for these diseases along with increasing disease-modifying therapy usage.

Curative Therapeutics Market- Geographical Insights

The North American Curative Therapeutics market is expected to hold a leading revenue share due to the prevalence of diseases, the well-developed healthcare system, research and development activities, and the developed pharmaceutical and biotechnology industries. For example, in April 2026, according to the Bureau of Labor Statistics (Gov), India is the leading exporter of pharmaceutical and medicine manufacturing in the U.S., exporting a value of USD 31,400 million, followed by Puerto Rico in second place with a value of USD 16,700 million; North Carolina (USD 14,300 million); California (USD 9,500 million); Illinois (USD 8,600 million); and Pennsylvania (USD 7,700 million). These export values highlight the well-established pharmaceutical manufacturing base across major U.S. states and territories.

The Asia Pacific region is expected to witness significant growth, backed by population growth, burden of disease, increased healthcare expenditures, and changing nature of the healthcare environment. June 2026, according to the Government of India, indicates that there will be continuous growth in the public health infrastructure through public health services provision in 186,000 Ayushman Arogya Mandirs functioning in India, which comprise 134,000 sub-health centres, 24,483 primary health centres, 5,474 urban primary health centres, 12,259 AYUSH centres, and 9,758 urban health and wellness centres as of June 5, 2026. Additionally, the PM-ABHIM has been allotted a total budget of Rs 64,180 crores and provides services to 23,224 rural health and wellness centres, 13,736 urban health and wellness centres, 3,389 block-level public health units, 744 integrated public health laboratories, and 631 critical care hospital blocks. These developments are expected to strengthen healthcare access and drive continued demand for healthcare services.

Curative Therapeutics Market- Competitive Landscape:

The Curative Therapeutics market is populated by firms like Gilead Sciences, Inc., Pfizer Inc., Amgen Inc., Novartis Pharmaceuticals Corporation, and Sarepta Therapeutics, Inc. The leading firms in the curative therapeutics industry are making efforts in trying to develop new drugs and treatments for the core diseases. Research and development by these firms using different strategies lead to bringing change in the competitive environment in the curative therapeutics industry. In February 2026, Gilead Sciences concluded its deal for the acquisition of Arcellx for about USD 7.8 billion in an effort to get the BCMA-directed CAR-T cell product candidate named Anto-cel used to treat multiple myeloma. These strategic initiatives strengthen innovation, expand treatment capabilities, and intensify competition across the curative therapeutics market.

Recent Developments:

In February 2026, Sarepta Therapeutics made an announcement about the market launch of ELEVIDYS (delandistrogene moxeparvovec) in Japan, in partnership with Chugai Pharmaceutical, thereby making their single-dose gene therapy .

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CURATIVE THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Sarepta Therapeutics, Inc.
  • Vertex Pharmaceuticals Incorporated
  • Alnylam Pharmaceuticals, Inc.
  • Amgen Inc.
  • Beam Therapeutics Inc.
  • CRISPR Therapeutics AG
  • Intellia Therapeutics, Inc.
  • Cartesian Therapeutics, Inc.
  • Curative Biotechnology, Inc.
  • CureAge Therapeutics
  • Jnana Therapeutics, Inc.
  • Kymera Therapeutics, Inc.
  • MiNA Therapeutics Ltd.
  • Seagen Inc.
  • Cellectis S.A.
  • Editas Medicine, Inc.
  • Sangamo Therapeutics, Inc.
  • Precision BioSciences, Inc.
  • Others

GLOBAL CURATIVE THERAPEUTICS MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

  • Cell Therapies
  • Gene Therapies
  • Biology Modifying Drugs

GLOBAL CURATIVE THERAPEUTICS MARKET, BY INDICATION- MARKET ANALYSIS, 2020 - 2033

  • Hepatitis C
  • Rare Diseases
  • Neurodegenerative Diseases
  • Musculoskeletal Disorders
  • Cancer
  • Others

GLOBAL CURATIVE THERAPEUTICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Academic & Research Institutions
  • Pharmaceutical Companies
  • Others

GLOBAL CURATIVE THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Curative Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Curative Therapeutics Market Snippet by Type
    • 2.1.2. Curative Therapeutics Market Snippet by Indication
    • 2.1.3. Curative Therapeutics Market Snippet by End User
    • 2.1.4. Curative Therapeutics Market Snippet by Country
    • 2.1.5. Curative Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Curative Therapeutics Key Market Trends

  • 3.1. Curative Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Curative Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Curative Therapeutics Market Opportunities
  • 3.4. Curative Therapeutics Market Future Trends

4. Curative Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Curative Therapeutics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Curative Therapeutics Market Landscape

  • 6.1. Curative Therapeutics Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Curative Therapeutics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
    • 7.1.2. Cell Therapies
    • 7.1.3. Gene Therapies
    • 7.1.4. Biology Modifying Drugs

8. Curative Therapeutics Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2025 & 2033 (%)
    • 8.1.2. Hepatitis C
    • 8.1.3. Rare Diseases
    • 8.1.4. Neurodegenerative Diseases
    • 8.1.5. Musculoskeletal Disorders
    • 8.1.6. Cancer
    • 8.1.7. Others

9. Curative Therapeutics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Academic & Research Institutions
    • 9.1.3. Pharmaceutical Companies
    • 9.1.4. Others

10. Curative Therapeutics Market - By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Curative Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Curative Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Curative Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Curative Therapeutics Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Curative Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Curative Therapeutics Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Sarepta Therapeutics, Inc.
    • 11.2.2. Vertex Pharmaceuticals Incorporated
    • 11.2.3. Alnylam Pharmaceuticals, Inc.
    • 11.2.4. Amgen Inc.
    • 11.2.5. Beam Therapeutics Inc.
    • 11.2.6. CRISPR Therapeutics AG
    • 11.2.7. Intellia Therapeutics, Inc.
    • 11.2.8. Cartesian Therapeutics, Inc.
    • 11.2.9. Curative Biotechnology, Inc.
    • 11.2.10. CureAge Therapeutics
    • 11.2.11. Jnana Therapeutics, Inc.
    • 11.2.12. Kymera Therapeutics, Inc.
    • 11.2.13. MiNA Therapeutics Ltd.
    • 11.2.14. Seagen Inc.
    • 11.2.15. Cellectis S.A.
    • 11.2.16. Editas Medicine, Inc.
    • 11.2.17. Sangamo Therapeutics, Inc.
    • 11.2.18. Precision BioSciences, Inc.
    • 11.2.19. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us